Bill number does not exist. Enter a vaild keyword.

Committee Testimony and Witness Signup

SB0394 - Statewide Targeted Overdose Prevention (STOP) Act of 2022

Finance 2/17/2022 1:00:00 PM
Health and Government Operations 3/30/2022 1:30:00 PM
As of: 9/29/2022 1:07:34 AM
Name Organization Position Testimony Committee
President, President FAV Oral Testimony FIN
Townsend, Pegeen A. MedStar Health FAV SB 394 - Statewide Targeted Overdose Prevention ST FIN
Delbridge, Theodore Maryland Institute for EMS Systems (MIEMSS) FAV SB 394_Statewide Targeted Overdose Prevention (STO FIN
Taylor, Ralph "Doug" Somerset County Government FAV SB394- STOP Act Support .pdf FIN
Park, Ju Nyeong FAV Park LOS SB394.pdf FIN
Wall, Sarah R Street Institute FAV Final - MD SB 394 - testimony - Sarah Wall.pdf FIN
Nibber, D'Paul Maryland Association of Counties (MACo) FAV Oral Testimony
SB0394-FIN_MACo_SUP.pdf
FIN
Russell, Erin Maryland Department of Health FAV Oral Testimony FIN
Rickard, Robin Opioid Operational Command Center FAV Oral Testimony FIN
Grollmes, Joshua MATOD FWA MATOD - SB 394 FWA - Naloxone.pdf FIN
Kasemeyer, Pam FAV No Testimony FIN
Ciekot, Ann NCADD-Maryland FWA Oral Testimony
NCADD-MD - SB 394 FWA - Naloxone.pdf
FIN
Shaklee, Christina FWA Copy of Statewide Targeted Overdose Prevention Act FIN
Beskid, Jennifer Department of Public Safety and Correctional Services FWA SB0394 - Naloxone - SWA.pdf FIN
Gudlavalleti, Rajani Baltimore Harm Reduction Coalition FWA SB394_BHRC_FAV WITH AMENDMENT_STOP ACT.pdf FIN
Shek, Heather Maryland Department of Health FAV 9a - SB 394 - X - FIN - MDH - LOS - ADMINISTRATION FIN
Hames, Shari FAV SB394_HamesRN.pdf FIN
(MD), State of Maryland FAV 9b - SB 394 - X - FIN - OOCC - LOS.pdf FIN
Livshin, Michelle On Our Own of Maryland, Inc. FWA 2022 -SB394-FAVAMEND-OOOMD.pdf FIN
State of, Maryland FWA 9c - SB 394 - FIN - MACHO LOSWA.pdf FIN
Dorrien, Erin Maryland Hospital Association INFO SB 394 Statewide Targeted Overdose Prevention (STO FIN
Burrell, Deborah Strengthening the Mid-Atlantic Region for Tomorrow/Burrell International Group FAV SB394_SMART_FAV.pdf FIN
Doyle, Lori FWA SB 394-CBH-FWA.pdf FIN
Martin, Dan Mental Health Association of Maryland FAV SB0394 STOP Act.pdf FIN
Whitaker, Jake FWA Oral Testimony
Senate Bill 394 - Statewide Targeted Overdose Pre
FIN
Coble, Annie Johns Hopkins INFO SB394 - Hopkins - LOI.pdf FIN
Evans Arthurs, Maureen Howard County Government FAV CEBall_SB 394_ Support_STOP Act 2022_Final.pdf FIN
Testimony, All N/A Merged Testimony as of 2-17-2022 at 1005 AM FIN
President, President FAV Oral Testimony HGO
Rosen-Cohen, Nancy NCADD-Maryland FAV NCADD-MD - SB 394 FWA - Naloxone - House.pdf HGO
Fry, Donald Greater Baltimore Committee FAV SB0394 - 3.30.22 -- (Opposite) Statewide Targeted HGO
Beskid, Jennifer Department of Public Safety and Correctional Services FAV SB0394 (3rd Reader) - Opioid Reversal Drug - SUP.p HGO
Dorrien, Erin Maryland Hospital Association INFO SB 394 STOP Act Crossover Testimony.pdf HGO
Nibber, D'Paul Maryland Association of Counties (MACo) FAV SB0394-HGO_MACo_SUP.pdf HGO
Grollmes, Joshua MATOD FAV MATOD - SB 394 FWA - Naloxone - House.pdf HGO
Whitaker, Jake FAV Oral Testimony
Senate Bill 394 - Statewide Targeted Overdose Prev
HGO
Shek, Heather Maryland Department of Health FAV 12a - X - SB 394 - HGO - MDH - LOS.docx.pdf HGO
(MD), State of Maryland FAV 12b - SB 394 - HGO - OOCC - LOS.pdf HGO
State of, Maryland FAV SB 394 - HGO - MACHO - LOSAA.pdf HGO
Townsend, Pegeen A. MedStar Health FAV SB 394 - Statewide Targeted Overdose Prevention ST HGO
Click to return on the top page